| Structure | Chemical Name | CAS | MF |
|
DONKEY IGG, WHOLE MOLECULE, RHODAMINE
|
|
|
|
|
DONKEY IGG, WHOLE MOLECULE, FLUORESCEIN
|
|
|
|
|
DONKEY IGG F(AB')2 FRAGMENT, TEXAS RED
|
|
|
|
|
DONKEY IGG F(AB')2 FRAGMENT
|
|
|
|
|
DONKEY IGG F(AB')2 FRAGMENT, RHODAMINE
|
|
|
|
|
DONKEY IGG, WHOLE MOLECULE, BIOTIN
|
|
|
|
|
DONKEY IGG F(AB')2 FRAGMENT, FLUORESCEIN
|
|
|
|
|
DONKEY IGG F(AB')2 FRAGMENT, BIOTIN
|
|
|
|
|
DONKEY IGG, WHOLE MOLECULE, ALKALINE PHOSPHATASE
|
|
|
|
|
DONKEY SERUM
|
|
|
|
|
DONKEY IGG, WHOLE MOLECULE
|
|
|
|
|
DONKEYGAMMAGLOBULIN
|
|
|
|
|
DONKEYSERUM(NORMAL)
|
|
|
|
|
DONKEYIGGWHOLEMOLECULE,PHYCOERYTHRINR-PE
|
|
|
|
|
DONKEYIGGF(AB')2FRAGMENT,CYANINECY3
|
|
|
|
|
DONKEYIGGF(AB')2FRAGMENT,FITC
|
|
|
|
|
DONKEYIGGWHOLEMOLECULE,FITC
|
|
|
|
|
DONKEYIGGF(AB')2FRAGMENT,HRP
|
|
|
|
|
DONKEYIGGWHOLEMOLECULE,CYANINECY5
|
|
|
|
|
DONKEYIGG
|
|
|
|
|
DONKEYIGGWHOLEMOLECULE,APC
|
|
|
|
|
DONKEYIGGF(AB')2FRAGMENT,APC
|
|
|
|
|
DONKEYIGGF(AB')2FRAGMENT,BIOTIN-SP
|
|
|
|
|
DONKEYIGGWHOLEMOLECULE,CYANINECY3
|
|
|
|
|
DONKEYSERUM(WHOLE),RABBITANTI-
|
|
|
|
|
DONKEYIGGF(AB')2FRAGMENT,CYANINECY5
|
|
|
|
|
DONKEYIGGWHOLEMOLECULE,HRP
|
|
|
|
|
DONKEYIGGWHOLEMOLECULE,BIOTIN-SP
|
|
|
|
|
don juan protein
|
|
|
|
DONNAIENIN C
|
209116-40-5
|
C37H66O9
|
|
|
Donnatal
|
|
|
|
|
DPD (NESSLERISER) TABLETS NO 1
|
|
|
|
DOOCTACONTANE
|
7719-95-1
|
C82H166
|
|
DPDPB
|
|
C20H26N4O2S4
|
|
DPDPE [TYROSYL-3,6-3H(N)]-
|
|
C30H37N5O7S2T2
|
|
DPDPE
|
88373-73-3
|
C30H39N5O7S2
|
|
|
DONORBREASTMILK
|
|
|
|
|
DonorGoatSerum:
|
|
|
|
|
DONOR EQUINE SERUM
|
|
|
|
|
DonorBovineSerum:
|
|
|
|
|
Donor Calf Serum gamma Irradiated
|
|
|
|
|
Donor Bovine Serum gamma Irradiated
|
|
|
|
|
Donor Bovine Serum Heat Inactivated
|
|
|
|
|
Donor Calf Serum Heat Inactivated
|
|
|
|
|
Donor Horse Serum Heat Inactivated
|
|
|
|
|
Don-1 protein
|
|
|
|
|
DON protocol
|
|
|
|
|
DPD REAGENT
|
|
|
|
|
DPD SIMPLY
|
|
|
|
|
DPE-II zinc plating bright additive
|
|
C9H21ClN2O
|
|
|
Dontisolon
|
76403-99-1
|
|
|
|
DON Standard Solution
|
|
|
|
|
dopachrome oxidoreductase
|
|
|
|
dopachrome
|
3571-34-4
|
C9H7NO4
|
|
|
DOPA dioxygenase
|
|
|
|
|
Dopa Decarboxylase
|
|
|
|
|
DOPA, L-(RG)
|
|
|
|
Dopamine 3-β-D-Glucuronide Sodium Salt
|
69975-91-3
|
C14H19NO8
|
|
|
Dopamine Transporter (Extracellular Loop 2) Polyclonal Antibody
|
|
|
|
|
Dopamine β-hydroxylase (N-Term: human) Polyclonal Antibody
|
|
|
|
|
Dopamine β-hydroxylase (C-Term: human) Polyclonal Antibody
|
|
|
|
|
Dopamine Transporter (C-Term) Polyclonal Antibody
|
|
|
|
DOPAMINE, [7,8-3H(N)]
|
|
C8H9NO2T2
|
|
|
dopamine-binding protein
|
|
|
|
|
DOPAMINE D2 RECEPTOR (CYS 271-272-282)
|
|
|
|
Dopamine, 3-fluoro-
|
71144-37-1
|
C8H10FNO2
|
|
|
DOPAMINE RECEPTOR D1A CONTROL PEPTIDE
|
|
|
|
|
DOPAMINE RECEPTOR SUBTYPE 2 SHORT HUMAN
|
|
|
|
DOPAMINE HCL (RING-D3, 2,2-D2)
|
|
C8H6D5NO2
|
|
|
dopamine D5 receptor
|
137750-35-7
|
|
|
|
dopamine-releasing factor
|
|
|
|
Dopamine
|
645-31-8
|
C8H12BrNO2
|
|
|
dopamine D1C receptor
|
|
|
|
dopamine, Gly-Pro-amide-
|
117992-61-7
|
C15H19N3O5
|
|
|
DopamineD3Receptor(A.A.2-10)
|
|
|
|
|
Dopamine Agents
|
|
|
|
|
dopamine-D3 receptor
|
|
|
|
|
DOPAMINE RECEPTOR D2 (L/S), HUMAN, 19AA WITHIN NT EXTRACELLULAR DOMAIN
|
|
|
|
|
DOPAMINE RECEPTOR D4, MOUSE, 10AA WITHIN 3RD EXTRACELLULAR DOMAIN
|
|
|
|
|
dopamine melanin
|
|
|
|
|
Dopamine Agonists
|
|
|
|
DOPAMINE HYDROCHLORIDE , USP
|
|
C8H12ClNO2
|
|
DOPAMINE, [8-14C]
|
|
C8H11NO2
|
|
|
dopamine D4 receptor
|
137750-34-6
|
|
|
|
DopamineD4Receptor(A.A.176-185)
|
|
|
|
DOPAMINE HCL (1,1,2,2-D4)
|
|
C8H7D4NO2
|
|
dopamine, Lys-Pro-amide-
|
117992-60-6
|
C19H28N4O5
|
|
|
Dopamine Antagonists
|
|
|
|
|
Dopamine Uptake Inhibitors
|
|
|
|
|
dopamine beta-hydroxylase
|
9013-38-1
|
|
|
|
DOPAMINE D1 RECEPTOR (AC-9-21)
|
|
|
|
|
DOPA melanin
|
63194-25-2
|
|
|
|
DOPAMINE RECEPTOR D2 POSITIVE CONTROL (HUMAN)
|
|
|
|
|
DOPAMINE RECEPTOR D2 (L/S), HUMAN, 28AA 3RD CYTOPLASMIC LOOP
|
|
|
|
|
DOPAMINE RECEPTOR SUBTYPE 2 LONG HUMAN
|
|
|
|
Dopamine hydrochloride
|
62-31-7
|
C8H12ClNO2
|
|
|
DOPAMINE RECEPTOR SUBTYPE 4.4 HUMAN
|
|
|
|
dopamine, N-benzyloxycarboxyl-Lys-Pro-amide-
|
117992-59-3
|
C27H34N4O7
|
|
dopamine 4-O-sulfate
|
38339-02-5
|
C8H11NO5S
|
|
|
DOPAMINE RECEPTOR SUBTYPE 4.7 HUMAN
|
|
|